4.8 Article

Autologous blood extracellular vesicles and specific CD4+ T-cell co-activation

期刊

FRONTIERS IN IMMUNOLOGY
卷 13, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2022.992483

关键词

CD4+T lymphocytes; sCD27; immunoregulation; autotransfusion; autologous extracellular vesicles

资金

  1. scientific committee of Agence Francaise de Lutte contre le Dopage (AFLD)
  2. World Antidoping Agency (WADA)
  3. Etablissement Francais du Sang
  4. INSERM
  5. Universite Paris-Est Creteil

向作者/读者索取更多资源

Autologous EVs may modulate the function of immune system cells, specifically CD4(+) T lymphocytes, but their immunomodulatory role is different from heterologous EVs. Autologous EVs can increase CD4(+) T lymphocyte proliferation, but T-cell receptor engagement is required.
Extracellular vesicles (EVs), which are generated by cell membrane budding in diverse cells, are present in variable numbers in the blood. An immunoregulatory role has been demonstrated principally for heterologous EVs, but the function of the EVs present naturally in blood remains unknown. We hypothesize that these autologous EVs might also modulate the phenotype and function of immune system cells, especially CD4(+) T lymphocytes (TLs), as previously described for heterologous EVs. Several membranes and soluble immunoregulatory molecules were studied after the treatment of CD4(+) TLs with autologous EVs. No direct activation was detected with autologous EVs, contrasting with the findings for heterologous EVs. However, following treatment with autologous EVs, a soluble form of CD27 (sCD27) was detected. sCD27 is strongly associated with lymphoproliferation. Autologous EVs have been shown to increase TL proliferation only after T-cell receptor (TcR) engagement due to polyclonal or specific-antigen stimulation. Our results therefore suggest that the EVs present in the blood have an immunomodulatory role different from that of heterologous EVs. These findings should be taken into account in future studies, particularly those focusing on infectious diseases, autotransfusion or doping practices.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据